Serious threat to human health caused by bacterial infection persists as a global concern. It becomes more serious when the burden of multidrug-resistance bacteria is in the increasing trend. To overcome, researches have been conducted to develop antibacterial agents from plant-derived bioactive compounds. This review article focuses on the antibacterial activities of plant extracts from seven Annonaceae members, namely Annona muricata, Annona reticulata, Annona squamosa, Cananga odorata, Annona hypoglauca, Polyalthia longifolia, and Xylopia aethiopica. First, ethnomedical uses of the aforementioned plants are discussed and followed by the screening results of related phytochemicals. Among many secondary metabolites contained in the extracts of Annonaceae spp., anonaine, nornuciferine, and liriodenine are common and bioactive. The extracts were reported to have bacteriostatic and bactericidal properties against a wide spectrum of bacteria, including multidrug-resistant Escherichia coli, Staphylococcus aureus, Bacillus cereus, Enterococcus faecalis, Enterobacter aerogenes, Enterobacter cloacae, Salmonella choleraesuis, Salmonella typhimurium, and Shigella dysenteriae. We conclude that investigation on the extracts from Annonaceae spp. could contribute to the development of antibacterial agents that could be used against multidrug-resistant bacteria.
Keywords: Annonaceae; antimicrobial; drug development; multidrug resistant; secondary metabolite.
Copyright: © 2022 Journal of Advanced Pharmaceutical Technology & Research.